ArticlePloS one2025
Orthogonally polarized dual-wavelength Nd:GdVO4/Nd:YVO4 laser at 1341 and 1342 nm with adjustable power ratio.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A continuous-wave (CW) orthogonally polarized dual-wavelength (OPDW) Nd:GdVO4/Nd:YVO4 laser at 1341 and 1342 nm on the 4F3/2 →4I13/2 transition was realized using in-band laser diode (LD) pumping with tunable wavelength from 909.40 to 915.02 nm for the first time. The operating temperature of the LD and the position of the pump beam waist were optimized to achieve high efficiency and balanced output powers of the OPDW laser. The OPDW laser at 1341 and 1342 nm was obtained with the highest total output power of 6.15 W and the power ratio of 1:1. The highest total slope efficiency and total optical-to-optical conversion efficiency with respect to the absorbed pump power at 913.61 nm were 34.9% and 32.0%, respectively. The OPDW laser at 1341 and 1342 nm have important application prospects in the fields of laser medicine, scientific research and terahertz radiation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.